Trials / Recruiting
RecruitingNCT06462378
Proton Therapy for Locally Advanced Cervical Cancer
Proton Therapy in Locally Advanced Cervical Cancer in Combination With Concomitant Chemotherapy and Brachytherapy
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this protocol is to determine toxicity and efficacy of proton therapy in combination with standard concomitant platinum-based chemotherapy and standard image-guided adaptive brachytherapy (IGABT) in patients with locally advanced cervical cancer (LACC). The over-all aim is to maintain a high disease control and at the same time reduce acute morbidity as well as late side effects after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Proton therapy | External beam proton therapy combined with standard cisplatin and brachytherapy |
Timeline
- Start date
- 2024-05-20
- Primary completion
- 2029-05-20
- Completion
- 2034-05-20
- First posted
- 2024-06-17
- Last updated
- 2024-06-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06462378. Inclusion in this directory is not an endorsement.